BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5086118)

  • 1. Lactulose: comments on mechanism of action and current status.
    Conn HO
    Conn Med; 1972 Oct; 36(10):582-6. PubMed ID: 5086118
    [No Abstract]   [Full Text] [Related]  

  • 2. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
    Elkington SG; Floch MH; Conn HO
    N Engl J Med; 1969 Aug; 281(8):408-12. PubMed ID: 4894464
    [No Abstract]   [Full Text] [Related]  

  • 3. Lactulose in the treatment of acute and chronic hepatic encephalopathy.
    Fung WP; Khoo OT
    Singapore Med J; 1971 Jun; 12(3):176-80. PubMed ID: 5094427
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lactulose in the therapy of porto-systemic encephalopathy].
    Almici C; Inzoli MR; Poloni AE; Zambruni A
    Minerva Med; 1973 Dec; 64(87):4596-603. PubMed ID: 4774227
    [No Abstract]   [Full Text] [Related]  

  • 5. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.
    Zeegen R; Drinkwater JE; Fenton JC; Vince A; Dawson AM
    Q J Med; 1970 Apr; 39(154):245-63. PubMed ID: 5449591
    [No Abstract]   [Full Text] [Related]  

  • 6. Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action of portal systemic encephalopathy.
    Avery GS; Davies EF; Brogden RN
    Drugs; 1972; 4(1):7-48. PubMed ID: 4564869
    [No Abstract]   [Full Text] [Related]  

  • 7. Lactulose: a drug in search of a modus operandi.
    Conn HO
    Gastroenterology; 1978 Mar; 74(3):624-6. PubMed ID: 24572
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatic encephalopathy and its therapy with lactulose].
    Pericoli F
    Policlinico Prat; 1971 Jun; 78(12):509-14. PubMed ID: 5568016
    [No Abstract]   [Full Text] [Related]  

  • 9. The mechanism of action of lactulose in portal-systemic encephalopathy. Non-ionic diffusion of ammonia in the canine colon.
    Bircher J; Haemmerli UP; Trabert E; Largiader F; Mocetti T
    Rev Eur Etud Clin Biol; 1971 Apr; 16(4):352-7. PubMed ID: 5564547
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the action mechanism of lactulose in hepatic coma--clarification of colon urease activity using C-14 urea in rats].
    Bircher J; Gmünder U; Haemmerli UP; Müller-Duysing W; Bally G; Haemmerli G; Hoffmann K
    Strahlentherapie Sonderb; 1968; 67():330-6. PubMed ID: 5719130
    [No Abstract]   [Full Text] [Related]  

  • 11. [1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
    Paris J; Merveille P; Molimard R
    Presse Med (1893); 1970 Jun; 78(30):1367-8. PubMed ID: 5421555
    [No Abstract]   [Full Text] [Related]  

  • 12. The mechanism of action of lactulose in portal systemic encephalopathy: colonic bacterial urease activity and bacterial flora in rats.
    Bircher J; Haemmerli UP; Müller-Duysing W; Bally G; Haemmerli G; Hoffmann K
    Rev Eur Etud Clin Biol; 1970 Dec; 15(10):1096-100. PubMed ID: 5517889
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lactulose in the treatment of chronic portosystemic encephalopathies].
    Seidlová V
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):201-7. PubMed ID: 4447986
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lactulose in the treatment of hepatic (pre)coma].
    Grijm R
    Ned Tijdschr Geneeskd; 1978 Feb; 122(6):198-200. PubMed ID: 24187
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of lactulose in the treatment of porto-systemic encephalopathy and chronic constipation].
    Azzena D; Arfini G; Melli E
    Recenti Prog Med; 1972 Mar; 52(3):273-84. PubMed ID: 5067694
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
    Pirotte J; Guffens JM; Devos J
    Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
    [No Abstract]   [Full Text] [Related]  

  • 17. The many effects of lactulose: a rational approach to its therapeutic use.
    Bircher J
    Drugs; 1972; 4(1):1-3. PubMed ID: 4637574
    [No Abstract]   [Full Text] [Related]  

  • 18. Lactulose treatment of hepatic encephalopathy: effects on carbohydrate metabolism and colonic hydrogen ion concentration.
    Trey C; Brown H; Goransky L; McDermott WV
    Surg Forum; 1970; 21():355-6. PubMed ID: 4936990
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions of lactulose and neomycin.
    Conn HO
    Drugs; 1972; 4(1):4-6. PubMed ID: 4637575
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.
    Bircher J; Haemmerli UP; Scollo-Lavizzari G; Hoffmann K
    Am J Med; 1971 Aug; 51(2):148-59. PubMed ID: 5095524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.